| Title: |
Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma |
| Authors: |
Willis, Brandon S.Aff1; Mongeon, KevinAff1; Dry, HannahAff1; Neveras, India L.Aff1; Bryan, NadezdaAff1; Pandya, MeghanaAff1; Roderick-Richardson, JustineAff1; Xu, WendanAff2; Yang, LiAff2; Rosen, AlanAff1; Reimer, CorinneAff1; Tuskova, LilianaAff3; Klener, PavelAff3; Mettetal, Jerome T.Aff1; Lenz, GeorgAff2; Barry, Simon T.Aff4, IDs41375024024019_cor16 |
| Source: |
Leukemia. 38(12):2663-2674 |
| Database: |
Springer Nature Journals |